- AU$5.74m
- AU$0.97m
- AU$3.21m
Brief: Tissue Repair Posts FY Loss Attributable Of A$5.4 Million
Brief: Tissue Repair Says Formally Applied To ASX Requesting Its Removal From Official List Of ASX
Brief: Tissue Repair Signs A Multi-Year Distribution Agreement With Advanced Cosmeceuticals Pty
Australia's Tissue Repair rises to 3-month high on securing distributor for flagship product
Brief: Tissue Repair Appoints Dion Cohen As CFO
Brief: Australian Government Takeovers Panel Receives Application From Tissue Repair
Brief: Australian Government Takeovers Panel Receives Application From Tissue Repair
Brief: Tissue Repair Says Tony Charara Appointed As CEO
Australia's Tissue Repair climbs on TGA product approval
Brief: Tissue Repair Says TGA Approval Granted For Tissue Repair's TR Pro
Australia's Tissue Repair eyes best day in over 7 months on US patent
Brief: Tissue Repair Ltd Says Third Us Patent Granted For Tissue Repair Glucoprime
Australia's Tissue Repair eyes best day ever on FDA phase 3 approval
Brief: Tissue Repair Says FDA Clears Phase 3 Clinical Program For Drug Candidate TR-987
Brief: Tissue Repair Expects To Be Able To Access Funds Held At SVB On 14 March
Brief: Tissue Repair Says Company Held Cash Of $2.188 Million With Silicon Valley Bank
Brief: Tissue Repair Posts Loss For HY Attributable A$3.2 Mln
Brief: Tissue Repair Receives Response From FDA Which Clarifies Path To Phase 3 Trials
Australia's Tissue Repair climbs on second U.S. patent